VAN BEEK JEROEN B

CIK 00017436622 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001743662

Recent Transactions

50 trades

Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-16$7.50/sh−16,074→ 333,726 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-11$8.20/sh−36,592→ 349,800 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-10$8.00/sh−13,109→ 386,392 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-08$8.00/sh−299→ 399,501 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-20$9.36/sh−1,070→ 399,800 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-19$9.36/sh−1,070→ 399,800 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-09-02$7.89/sh−493→ 400,870 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16+15,000→ 401,363 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16$8.30/sh−15,590→ 386,363 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-20$5.21/sh−1,058→ 401,953 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+14,000→ 403,011 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+26,000→ 26,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-06-03$3.63/sh−515→ 389,011 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-05-17$4.40/sh−15,262→ 389,526 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-04-20$6.68/sh−852→ 404,788 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-03-02$9.01/sh−516→ 382,384 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-02-16$8.32/sh−15,322→ 382,900 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-20$8.75/sh−4,656→ 398,222 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-18+23,256→ 405,640 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-01-18+56,744→ 56,744 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-12-02$17.06/sh−514→ 402,878 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-11-16$21.13/sh−15,203→ 403,392 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-10-01$25.07/sh−3,413→ 418,595 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-30$25.17/sh−12,171→ 422,008 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-29$25.04/sh−1,000→ 434,179 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-17$25.08/sh−5,916→ 435,179 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-09-02$19.86/sh−513→ 441,095 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-08-17$17.82/sh−15,205→ 441,608 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-06-03$22.87/sh−508→ 456,813 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-05-18$22.80/sh−15,201→ 457,321 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-02$37.93/sh−512→ 472,522 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$39.21/sh−1,600→ 488,230 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$38.62/sh−4,332→ 489,830 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$40.32/sh−700→ 494,162 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-23$39.18/sh−1,418→ 494,862 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$42.82/sh−2,200→ 496,280 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-22$41.53/sh−600→ 498,480 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-19$41.71/sh−4,165→ 499,080 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$41.50/sh−750→ 503,245 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$40.44/sh−800→ 503,995 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-18$39.83/sh−535→ 504,795 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$39.65/sh−15,196→ 490,134 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$38.42/sh−500→ 507,130 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$39.72/sh−400→ 506,730 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$41.22/sh−1,300→ 505,430 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-17$41.56/sh−100→ 505,330 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-16$41.76/sh−2,700→ 508,030 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-16$42.52/sh−400→ 507,630 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-02-02$41.19/sh−48,910→ 510,730 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-01-19+35,000→ 559,640 total

Companies

Recent Filings

Address

7000 SHORELINE COURT, SUITE 201

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov